Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone to Prevent Migraine Relapse in Children
NCT02903680Phase 1Completed
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- May 2014
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in migraine comparing Dexamethasone Group with Placebo Group (2 arms). Primary endpoint: Incidence of relapse following discharge from the ED at 48 hours. Started May 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02903680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903680.